Fertility company Spermosens announces that development of the Juno-Checked Generation 3 system has been completed. This is stated in a press release. The company is preparing to now initiate patient recruitment for a clinical validation study at Reproductive Medicine Center, RMC, in Malmö.Patient recruitment is expected to begin shortly. The study is expected to be completed by the end of the year.